Plaque Buildup May Serve as Early Biomarker for ALZ's Disease, University of Pennsylvania Study
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
The trajectory of amyloid plaque buildup -- clumps of abnormal proteins in the brain linked to Alzheimer's disease -- may serve as a more powerful biomarker for early detection of cognitive decline rather than using the total amount to gauge risk, researchers from Penn Medicine's Department of Radiology suggest in a new study published online July 15 in Neurobiology of Aging.
Hey, check out all the engineering jobs. Post your resume today!
The trajectory of amyloid plaque buildup -- clumps of abnormal proteins in the brain linked to Alzheimer's disease -- may serve as a more powerful biomarker for early detection of cognitive decline rather than using the total amount to gauge risk, researchers from Penn Medicine's Department of Radiology suggest in a new study published online July 15 in Neurobiology of Aging.
Hey, check out all the engineering jobs. Post your resume today!